MKGAF.US MERCK Kommanditgesellschaft auf Aktien

Healthcare Pharmaceuticals USA Stocks
562.20 USD
Close of Nov 16, 2026
112.78 175.56
Market cap
USD 72.7B
P/E
32.5x
P/B
2.10x
ROE
7.6%
Dividend yield
1.54%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is MKGAF.US undervalued?

Graham number
Price562.20
Graham value322.85
Premium74.1%

MKGAF.US trades 74.1% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

MERCK Kommanditgesellschaft auf Aktien fundamental analysis

No fundamental analysis for MERCK Kommanditgesellschaft auf Aktien yet.

MERCK Kommanditgesellschaft auf Aktien stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About MERCK Kommanditgesellschaft auf Aktien

Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for research, production, and testing to lab water instruments, microbiology and biomo…

Full company profile